Test-retest reliability of saccadic measures in subjects at risk for Huntington disease

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5707-5711

  Blekher, Tanya ^a   Weaver, Marjorie R ^b   Cai, Xueya ^c   Hui, Siu ^c   Marshall, Jeanine ^b   Jackson, Jacqueline Gray ^b   Wojcieszek, Joanne ^d   Yee, Robert D ^a   Foroud, Tatiana M ^b  

^a Departments of Ophthalmology   (United States)

^b Medical and Molecular Genetics   (United States)

^c Division of Biostatistics   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ERROR; FEMALE; GENDER; GENE; HD GENE; HUMAN; HUNTINGTON CHOREA; LATENT PERIOD; MALE; MEMORY; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; TASK PERFORMANCE; TEST RETEST RELIABILITY; DISEASE COURSE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REACTION TIME; REPRODUCIBILITY;

BIOLOGICAL MARKER;

ADULT; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; REACTION TIME; REPRODUCIBILITY OF RESULTS; SACCADES;

EID: 73349086234     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3538     Document Type: Article

References (32)

1. Amado I, Landgraf S, Bourdel MC, Leonardi S, Krebs MO. Predictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients. J Psychiatry Neurosci. 2008;33:17-22.
2. Calkins ME, Curtis CE, Iacono WG, Grove WM. Antisaccade performance is impaired in medically and psychiatrically healthy biological relatives of schizophrenia patients. Schizophr Res. 2004;71: 167-178.
3. Crawford TJ, Sharma T, Puri BK, Murray RM, Berridge DM, Lewis SW. Saccadic eye movements in families multiply affected with schizophrenia: the Maudsley Family Study. Am J Psychiatry. 1998; 155:1703-1710.
4. Curtis CE, Calkins ME, Grove WM, Feil KJ, Iacono WG. Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives. Am J Psychiatry. 2001; 158:100-106.
5. Curtis CE, Calkins ME, Iacono WG. Saccadic disinhibition in schizophrenia patients and their first-degree biological relatives: a parametric study of the effects of increasing inhibitory load. Exp Brain Res. 2001;137:228-236.
6. McDowell JE, Myles-Worsley M, Coon H, Byerley W, Clementz BA. Measuring liability for schizophrenia using optimized antisaccade stimulus parameters. Psychophysiology. 1999;36:138-141.
7. Nieman D, Becker H, van de Fliert R, et al. Antisaccade task performance in patients at ultra high risk for developing psychosis. Schizophr Res. 2007;95:54-60.
8. Blekher T, Johnson SA, Marshall J, et al. Saccades in presymptom-atic and early stages of Huntington disease. Neurology. 2006;67: 394-399.
9. Golding CV, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C. Identification of an oculomotor biomarker of preclinical Hunting-ton disease. Neurology. 2006;67:485-487.
10. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72: 971-983.
11. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985;44:559-577.
12. Aylward EH, Li Q, Stine OC, et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology. 1997;48:394-399.
13. Aylward EH, Codori AM, Rosenblatt A, et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Hunting-ton's disease. Mov Disord. 2000;15:552-560.
14. Rosas HD, Liu AK, Hersch S, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology. 2002;58:695-701.
15. Beglinger LJ, Nopoulos PC, Jorge RE, et al. White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol. 2005;18:102-107.
16. Paulsen JS, Magnotta VA, Mikos AE, et al. Brain structure in pre-clinical Huntington's disease. Biol Psychiatry. 2006;59:57-63.
17. Rosas HD, Koroshetz WJ, Chen YI, et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morpho-metric analysis. Neurology. 2003;60:1615-1620.
18. Reading SA, Yassa MA, Bakker A, et al. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study. Psychiatry Res. 2005;140:55-62.
19. Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C. Oculomotor deficits indicate the progression of Huntington's disease. Prog Brain Res. 2008;171:555-558.
20. Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T. Subtle changes among presymptomatic carriers of the Huntington's disease gene. J Neurol Neurosurg Psychiatry. 2000; 6:773-779.
21. Calkins ME, Iacono WG, Curtis CE. Smooth pursuit and antisac-cade performance evidence trait stability in schizophrenia patients and their relatives. Int J Psychophysiol. 2003;49:139-146.
22. Ettinger U, Kumari V, Crawford TJ, Davis RE, Sharma T, Corr PJ. Reliability of smooth pursuit, fixation, and saccadic eye movements. Psychophysiology. 2003;40:620-628.
23. Klein C, Berg P. Four-week test-retest stability of individual differences in the saccadic CNV, two saccadic task parameters, and selected neuropsychological tests. Psychophysiology. 2001;38: 704-711.
24. Klein C, Fischer B. Instrumental and test-retest reliability of sac-cadic measures. Biol Psychol. 2005;68:201-213.
25. Roy-Byrne P, Radant A, Wingerson D, Cowley DS. Human oculomotor function: reliability and diurnal variation. Biol Psychiatry. 1995;3:92-97.
26. Gooding DC, Mohapatra L, Shea HB. Temporal stability of saccadic task performance in schizophrenia and bipolar patients. Psychol Med. 2004;34:921-932.
27. Huntington Study Group. Unified Huntington's disease rating scale: Reliability and consistency. Mov Disord. 1996;11:136-142.
28. Blekher TM, Yee RD, Kirkwood SC, et al. Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease. Vision Res. 2004;44:2729-2736.
29. Bahill AT, Clark MR, Stark L. The main sequence, a tool for studying human eye movements. Math Biosci. 1975;24:191-204.
30. Bartko JJ. Measurement and reliability: statistical thinking considerations. Schizophr Bull. 1991;17:483-489.
31. Konishi S. Normalizing and variance stabilizing transformations for intraclass correlations. Ann Inst Stat Math. 1985;37:87-94.
32. Konishi S, Gupta AK. Testing the quality of several intraclass correlation coefficients. J Stat Plan Infer. 1989;21:91-105.